CEMEX Will Contribute to Reconstruction of Notre-Dame Cathedral
Get Alerts CX Hot Sheet
Join SI Premium – FREE
MONTERREY, Mexico--(BUSINESS WIRE)-- CEMEX, S.A.B. de C.V. (“CEMEX”) (NYSE: CX) announced today that it will help rebuild Paris’ Notre-Dame Cathedral after the devastating fire that partly destroyed and ravaged the building, including the iconic church’s roof and spire.
In France, CEMEX will match the donations made by its employees to Fondation du patrimoine (French Heritage Foundation), a private organization dedicated to saving French cultural and natural heritage.
In addition, CEMEX will assist in the reconstruction efforts with the following:
- A high-quality range of technical & specialized products & services.
- The availability of our Research & Development centres based in Biel and Paris.
- Assistance with material specifications and mix designs through our Laboratory services.
CEMEX is a global building materials company that provides high-quality products and reliable services to customers and communities in more than 50 countries. CEMEX has a rich history of improving the wellbeing of those it serves through innovative building solutions, efficiency advancements, and efforts to promote a sustainable future. For more information, please visit: www.cemex.com
Follow us on: facebook.com/cemex, twitter.com/cemex, instagram.com/cemex/, youtube.com/cemex
CEMEX assumes no obligation to update or correct the information contained in this press release. CEMEX is not responsible for the content of any third-party website or webpage referenced to or accessible through this press release.
View source version on businesswire.com: https://www.businesswire.com/news/home/20190423005972/en/
Media Relations
Jorge Perez
+52(81) 8888-4334
[email protected]
Investor Relations
Eduardo Rendon
+52(81)
8888-4256
[email protected]
Analyst Relations
Lucy Rodriguez
+1(212) 317-6007
[email protected]
Source: CEMEX, S.A.B. de C.V.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- One Destination, Endless Possibilities: Wego and Tourism Malaysia Partner to Inspire MENA Discovery Ahead of Visit Malaysia 2026
- MGI Tech and Shanghai AI Laboratory Unveil ProtoPilot and BioLab Bench, Pioneering Physical AI for Life Sciences
- Ascletis Submits Two IND Applications to the U.S. FDA for the Treatment of Obesity: ASC36 Once-Monthly Injection, a Peptide Amylin Receptor Agonist, and ASC36_35 FDC Once-Monthly Injection, a Co-Formu
Create E-mail Alert Related Categories
Press ReleasesRelated Entities
TwitterSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share